Prestige Consumer Healthcare (PBH) Amortization of Deferred Charges (2010 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Amortization of Deferred Charges came in at $452000.0 in Q4 2025, up 4.15% year-on-year from $434000.0 in Q4 2024, and up 1.12% quarter-over-quarter from $447000.0 in Q3 2025.

Prestige Consumer Healthcare (PBH) Amortization of Deferred Charges (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Amortization of Deferred Charges history runs 16 years deep, the most recent figure standing at $452000.0 for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges rose 4.15% year-over-year to $452000.0 in Q4 2025; TTM through Dec 2025 was $1.8 million, a 37.14% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, down 66.53% from the prior year.
  • Amortization of Deferred Charges grew to $452000.0 in Q4 2025 per PBH's latest filing, from $447000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $1.8 million in Q1 2023 and bottomed at $428000.0 in Q3 2024.
  • The 5-year median for Amortization of Deferred Charges is $821500.0 (2022), against an average of $916950.0.
  • Across the five-year window, Amortization of Deferred Charges jumped 111.37% in 2021 and slumped 71.07% in 2025, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $1.4 million in 2021, then slumped by 40.77% to $815000.0 in 2022, then surged by 74.72% to $1.4 million in 2023, then tumbled by 69.52% to $434000.0 in 2024, then climbed by 4.15% to $452000.0 in 2025.
  • Per Business Quant, the three latest PBH Amortization of Deferred Charges figures stand at $452000.0 (Q4 2025), $447000.0 (Q3 2025), and $442000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Prestige Consumer Healthcare 2.41 Bn 2.35 Bn 157.37 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 452,000.00
Dec 31, 2025 452,000.00
Sep 30, 2025 447,000.00
Sep 30, 2025 447,000.00
Jun 30, 2025 442,000.00
Jun 30, 2025 442,000.00
Mar 31, 2025 438,000.00
Mar 31, 2025 438,000.00
Dec 31, 2024 434,000.00
Dec 31, 2024 434,000.00
Sep 30, 2024 428,000.00
Sep 30, 2024 428,000.00
Jun 30, 2024 454,000.00
Jun 30, 2024 454,000.00
Mar 31, 2024 1.51 Mn
Mar 31, 2024 1.51 Mn
Dec 31, 2023 1.42 Mn
Dec 31, 2023 1.42 Mn
Sep 30, 2023 1.32 Mn
Sep 30, 2023 1.32 Mn